IMVT
Ticker
Immunovant, Inc.
IMVT · Healthcare · Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseasesImmunovant, Inc. (IMVT), in the Healthcare sector, has 20 disclosed filings on Paydirt over the trailing twelve months from 9 corporate insiders: 1 purchase and 19 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Aug 20 and filed Aug 21. The most active filer was Peter Salzmann with 8 filings.
Add to watchlistFilings, ttm
20
1 buy · 19 sells
Traders, ttm
9
9 insiders
Volume, ttmiDollar value disclosed in the window
$364.4M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Aug 20
Filed Aug 21
ADViAverage daily dollar volume
$75.6M
market data
Share price · 12M
$43.82 (+181.1%)
Adjusted for splits and dividends.
Volume by month
Buys $686.9M
Sells $17.2M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
PSRecent filings
Melanie GloriaSALE
Chief Operating Officer
$135K3,056 sh × $44.16
Exec Aug 20
Filed Aug 21 · 4:03 PM ET Tiago GiraoSALE Chief Financial Officer $263K
6,798 sh × $38.69
Exec Jul 23
Filed Jul 24 · 5:57 PM ET Jay S StoutSALE Chief Technology Officer $111K
2,857 sh × $38.69
Exec Jul 23
Filed Jul 24 · 5:57 PM ET Eric VenkerSALE Chief Executive Officer $119K
3,092 sh × $38.48
Exec Jul 2
Filed Jul 6 · 5:01 PM ET Tiago GiraoSALE Chief Financial Officer $385K
10,000 sh × $38.46
Exec Jun 26
Filed Jun 26 · 5:30 PM ET Christopher Van TuylSALE Chief Legal Officer $683K
17,824 sh across 2 lots
Exec Jun 26
Filed Jun 26 · 5:30 PM ET Jay S StoutSALE Chief Technology Officer $1.5M
40,000 sh across 2 lots
Exec Jun 26
Filed Jun 26 · 5:30 PM ET Melanie GloriaSALE Chief Operating Officer $679K
17,714 sh across 2 lots
Exec Jun 26
Filed Jun 26 · 5:30 PM ET Andrew J. FromkinSALE Director $7.4M
221,951 sh across 2 lots
Exec May 28
Filed May 29 · 5:30 PM ET Atul PandeSALE Director $192K
6,000 sh × $32.00
Exec May 20
Filed May 20 · 5:30 PM ET Tiago GiraoSALE Chief Financial Officer $763K
25,760 sh × $29.62
Exec Apr 23
Filed Apr 24 · 5:30 PM ET Jay S StoutSALE Chief Technology Officer $214K
8,614 sh × $24.83
Exec Apr 8
Filed Apr 10 · 5:30 PM ET Melanie GloriaSALE Chief Operating Officer $217K
8,722 sh × $24.83
Exec Apr 8
Filed Apr 10 · 5:30 PM ET Christopher Van TuylSALE Chief Legal Officer $128K
5,165 sh × $24.83
Exec Apr 8
Filed Apr 10 · 5:30 PM ET Eric VenkerSALE Chief Executive Officer $308K
12,820 sh × $24.04
Exec Apr 2
Filed Apr 3 · 5:30 PM ET Christopher Van TuylSALE Chief Legal Officer $228K
8,529 sh × $26.78
Exec Dec 18 2025
Filed Dec 19 2025 · 5:30 PM ET Roivant Sciences Ltd.PURCHASE Director $350.0M
16,666,666 sh × $21.00
Exec Dec 12 2025
Filed Dec 12 2025 · 5:17 PM ET Douglas J. HughesSALE Director $303K
13,091 sh × $23.14
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET Andrew J. FromkinSALE Director $448K
19,351 sh × $23.14
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET Melanie GloriaSALE Chief Operating Officer $241K
10,251 sh × $23.54
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET Peter SalzmannSALE Chief Executive Officer $124K
8,321 sh × $14.89
Exec Apr 16 2025
Filed Apr 17 2025 · 5:30 PM ET Peter SalzmannSALE Chief Executive Officer $365K
28,094 sh × $12.99
Exec Apr 9 2025
Filed Apr 11 2025 · 5:30 PM ET Andrew J. FromkinSALE Director $129K
6,616 sh × $19.52
Exec Mar 7 2025
Filed Mar 11 2025 · 5:30 PM ET Peter SalzmannSALE Chief Executive Officer $322K
15,439 sh × $20.86
Exec Feb 19 2025
Filed Feb 21 2025 · 5:30 PM ET Peter SalzmannSALE Chief Executive Officer $199K
8,352 sh × $23.81
Exec Jan 15 2025
Filed Jan 17 2025 · 5:30 PM ET